FIELD: medicine.
SUBSTANCE: invention relates to novel compounds of formula 
or to its pharmaceutically acceptable salts, where n is 0 or 1; R1 represents H or F; R2 represents C1-4alkyl; R7 represents H or C1-4alkyl; and Z represents hydroxyl C1-6alkyl or C1-6alkoxycarbonyl, or 5- or 6-member heteroaromatic ring, which belongs to aromatic rings which have given number of atoms, of which at least one is N, O or S, the remaining being carbon atoms, and which also optionally has methyl substituting group. Invention also relates to pharmaceutical composition, to application of compounds, as well as to method of obtaining formula I compounds.
EFFECT: obtaining novel biologically active compounds, possessing activity of receptor 5-HT2A antagonists.
9 cl, 25 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THIAZOLYLPHENYL-BENZENESULFONAMIDO DERIVATIVES AS KINASE INHIBITORS | 2012 |
|
RU2606497C2 |
| NOVEL COMPOUNDS OF SUBSTITUTED N-(3-FLUOROPROPYL)PYRROLIDINE, METHODS FOR PRODUCTION THEREOF AND THERAPEUTIC APPLICATION THEREOF | 2017 |
|
RU2742278C2 |
| NEW SUBSTITUTED BIARYL COMPOUNDS AS INDOLAMINE-2,3-DIOXYGENASE (IDO) INHIBITORS | 2018 |
|
RU2786586C2 |
| PROTEIN KINASE INHIBITORS FOR ENHANCING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH | 2019 |
|
RU2822216C2 |
| BICYCLIC HETEROARYL DERIVATIVES AS CFTR STIMULATORS | 2017 |
|
RU2753056C2 |
| NEW COMPOUNDS FOR THE TREATMENT OF MAMMALIAN INFECTIONS | 2019 |
|
RU2798336C2 |
| CYCLIC IMINOPYRIMIDINE DERIVATIVES AS KINASE INHIBITORS | 2018 |
|
RU2801302C2 |
| TETRASUBSTITUTED ALKENE COMPOUNDS AND USE THEREOF | 2016 |
|
RU2733741C2 |
| 6,7-DIHYDRO-5H-PYRAZOLO[1,2-A]PYRAZOL-1-ONES REGULATING INFLAMMATORY CYTOKINES, (VARIANTS) AND PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2289584C2 |
| PRODRUG OF THE AMINO ACID DERIVATIVE | 2017 |
|
RU2739318C2 |
